Therefore, given the emerging evidence for non-anatomic contributors to OSA pathophysiology, as well as the advent of anti-obesity pharmacotherapy [16], the therapeutic landscape for the personalized management of OSA has evolved over the last decade
Within the first few weeks, she noticed that her cravings had diminished significantly, making it easier for her to stick to her dietary goals
National prescription drug spending grew 10% in 2024 alone, and GLP-1 medications are now estimated to account for 14% of all prescription drug spending in 2026
This level of support helps remove the guesswork and anxiety that can sometimes accompany new treatments
Although long-acting GnRH agonists suppress the release of LH and testosterone, GnRH agonists initially produce a rapid and transient increase in LH and testosterone levels, which is called the flare-up phenomenon, and may lead to side effects, such as bone pain and cardiovascular complications